A LC-MS/MS Method for Concurrent Determination of Nicotine Metabolites and Role of CYP2A6 in Nicotine Metabolism in U937 Macrophages: Implications in Oxidative Stress in HIV + Smokers

[1]  Defeng Wu,et al.  Ethanol Induction of CYP2A5: Permissive Role for CYP2E1 , 2011, Drug Metabolism and Disposition.

[2]  T. Fukami,et al.  Human CYP2A6 is regulated by nuclear factor-erythroid 2 related factor 2. , 2011, Biochemical pharmacology.

[3]  Anil Kumar,et al.  Effect of alcohol on drug efflux protein and drug metabolic enzymes in U937 macrophages. , 2011, Alcoholism, clinical and experimental research.

[4]  Chun-Fu Wu,et al.  Possible metabolic pathways of ethanol responsible for oxidative DNA damage in human peripheral lymphocytes. , 2011, Alcoholism, clinical and experimental research.

[5]  M. Saugy,et al.  Determination of nicotine and nicotine metabolites in urine by hydrophilic interaction chromatography-tandem mass spectrometry: Potential use of smokeless tobacco products by ice hockey players. , 2010, Journal of chromatography. A.

[6]  Anil Kumar,et al.  Effect of ethanol on spectral binding, inhibition, and activity of CYP3A4 with an antiretroviral drug nelfinavir. , 2010, Biochemical and biophysical research communications.

[7]  A. Mitra,et al.  Development and validation of a fast and sensitive bioanalytical method for the quantitative determination of glucocorticoids--quantitative measurement of dexamethasone in rabbit ocular matrices by liquid chromatography tandem mass spectrometry. , 2010, Journal of pharmaceutical and biomedical analysis.

[8]  J. Hakkola,et al.  Cytochrome P450 2A5 constitutive expression and induction by heavy metals is dependent on redox-sensitive transcription factor Nrf2 in liver. , 2010, Chemical research in toxicology.

[9]  W. Rickert,et al.  An improved headspace solid-phase microextraction method for the analysis of free-base nicotine in particulate phase of mainstream cigarette smoke. , 2010, Analytica chimica acta.

[10]  S. Tiffany,et al.  A novel validated procedure for the determination of nicotine, eight nicotine metabolites and two minor tobacco alkaloids in human plasma or urine by solid-phase extraction coupled with liquid chromatography-electrospray ionization-tandem mass spectrometry. , 2010, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[11]  Defeng Wu,et al.  Ethanol-induction of Cytochrome P 450 2 A 5 : Permissive Role for CYP 2 E 1 , 2010 .

[12]  A. Basu,et al.  Tobacco carcinogen induces microglial activation and subsequent neuronal damage , 2009, Journal of neurochemistry.

[13]  K. Anderson,et al.  Phenotypic CYP2A6 variation and the risk of pancreatic cancer. , 2009, JOP : Journal of the pancreas.

[14]  Somenath Roy,et al.  In Vitro Nicotine-Induced Oxidative Stress in Mice Peritoneal Macrophages: A Dose-Dependent Approach , 2009, Toxicology mechanisms and methods.

[15]  N. Benowitz.  Pharmacology of nicotine: addiction, smoking-induced disease, and therapeutics. , 2009, Annual review of pharmacology and toxicology.

[16]  N. Benowitz,et al.  Nicotine chemistry, metabolism, kinetics and biomarkers. , 2009, Handbook of experimental pharmacology.

[17]  J. Colacino,et al.  Alterations of cellular redox state during NNK-induced malignant transformation and resistance to radiation. , 2008, Antioxidants & redox signaling.

[18]  Rajagopal N. Aravalli,et al.  Potentiation of HIV-1 Expression in Microglial Cells by Nicotine: Involvement of Transforming Growth Factor-β1 , 2008, Journal of Neuroimmune Pharmacology.

[19]  R. Tyndale,et al.  Genetic variability in CYP2A6 and the pharmacokinetics of nicotine. , 2007, Pharmacogenomics.

[20]  L. Montaner,et al.  Advances in macrophage and dendritic cell biology in HIV‐1 infection stress key understudied areas in infection, pathogenesis, and analysis of viral reservoirs , 2006, Journal of leukocyte biology.

[21]  Mardge H. Cohen,et al.  Association of cigarette smoking with HIV prognosis among women in the HAART era: a report from the women's interagency HIV study. , 2006, American journal of public health.

[22]  P. Hollenberg,et al.  Effects of benzyl and phenethyl isothiocyanate on P450s 2A6 and 2A13: potential for chemoprevention in smokers. , 2006, Carcinogenesis.

[23]  C. Chuang,et al.  Synergistic DNA damage and lipid peroxidation in cultured human white blood cells exposed to 4‐(methyl‐nitrosamino)‐1‐(3‐pyridyl)‐1‐butanone and ultraviolet A , 2006, Environmental and molecular mutagenesis.

[24]  B. Rapkin,et al.  Tobacco use and readiness to quit smoking in low-income HIV-infected persons. , 2005, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[25]  S. Hecht,et al.  Metabolic activation of the tobacco carcinogen 4-(methylnitrosamino)-(3-pyridyl)-1-butanone by cytochrome P450 2A13 in human fetal nasal microsomes. , 2005, Chemical research in toxicology.

[26]  G. Byrd,et al.  A rapid LC-MS-MS method for the determination of nicotine and cotinine in serum and saliva samples from smokers: validation and comparison with a radioimmunoassay method. , 2005, Journal of chromatographic science.

[27]  Jun-yan Hong,et al.  METABOLISM OF NICOTINE AND COTININE BY HUMAN CYTOCHROME P450 2A13 , 2005, Drug Metabolism and Disposition.

[28]  A. Antinori,et al.  Human immunodeficiency virus infection and acquired immunodeficiency syndrome dementia complex: role of cells of monocyte-macrophage lineage. , 2005, Journal of neurovirology.

[29]  R. Tyndale,et al.  Decreasing smoking behaviour and risk through CYP2A6 inhibition. , 2003, Drug discovery today.

[30]  M. W. Ogden,et al.  Liquid chromatographic/tandem mass spectrometric method for the determination of the tobacco-specific nitrosamine metabolite NNAL in smokers' urine. , 2003, Journal of mass spectrometry : JMS.

[31]  K. Kedzierska,et al.  The role of monocytes and macrophages in the pathogenesis of HIV-1 infection. , 2002, Current medicinal chemistry.

[32]  T. Kamataki,et al.  ROLE OF HUMAN CYTOCHROME P450 (CYP) IN THE METABOLIC ACTIVATION OF NITROSAMINE DERIVATIVES: APPLICATION OF GENETICALLY ENGINEERED SALMONELLA EXPRESSING HUMAN CYP , 2002, Drug metabolism reviews.

[33]  R. Tyndale,et al.  Evaluation of methoxsalen, tranylcypromine, and tryptamine as specific and selective CYP2A6 inhibitors in vitro. , 2001, Drug metabolism and disposition: the biological fate of chemicals.

[34]  T. Cserháti,et al.  Analytical Determination of Nicotine and Related Compounds and their Metabolites , 2001 .

[35]  S. Hecht,et al.  2'-Hydroxylation of nicotine by cytochrome P450 2A6 and human liver microsomes: formation of a lung carcinogen precursor. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[36]  G. Pescarmona,et al.  Iron metabolism and HIV infection: reciprocal interactions with potentially harmful consequences? , 1999, Cell biochemistry and function.

[37]  Riley A. Davis,et al.  Chapter 14 – Determination of nicotine and its metabolites in biological fluids: in vivo studies , 1999 .

[38]  N. Avadhani,et al.  Preferential effects of nicotine and 4-(N-methyl-N-nitrosamine)-1-(3-pyridyl)-1-butanone on mitochondrial glutathione S-transferase A4-4 induction and increased oxidative stress in the rat brain. , 1998, Biochemical pharmacology.

[39]  D. Armstrong,et al.  Nicotine enantiomers and oxidative stress. , 1998, Toxicology.

[40]  W. Kozak,et al.  Immunomodulatory effects of cigarette smoke , 1998, Journal of Neuroimmunology.

[41]  L. Anderson,et al.  Enzymes involved in the bioactivation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in patas monkey lung and liver microsomes. , 1997, Carcinogenesis.

[42]  J. Piette,et al.  Iron and oxidative stress as a mechanism for the enhanced production of human immunodeficiency virus by alveolar macrophages from otherwise healthy cigarette smokers. , 1996, The Journal of infectious diseases.

[43]  E. Weinberg,et al.  Altered iron metabolism in HIV infection: mechanisms, possible consequences, and proposals for management. , 1996, Infectious agents and disease.

[44]  G. Stoner,et al.  Activation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in human lung microsomes by cytochromes P450, lipoxygenase, and hydroperoxides. , 1995, Cancer research.

[45]  L. Guay,et al.  Enhanced production of human immunodeficiency virus type 1 by in vitro-infected alveolar macrophages from otherwise healthy cigarette smokers. , 1995, The Journal of infectious diseases.

[46]  G. Byrd,et al.  Evidence for urinary excretion of glucuronide conjugates of nicotine, cotinine, and trans-3'-hydroxycotinine in smokers. , 1992, Drug metabolism and disposition: the biological fate of chemicals.

[47]  T. Aoyama,et al.  Nicotine metabolism by cDNA-expressed human cytochrome P-450s , 1992 .

[48]  R. Davis,et al.  The determination of nicotine and cotinine in plasma. , 1986, Journal of chromatographic science.

[49]  M. Curvall,et al.  Simultaneous determination of nicotine and cotinine in plasma using capillary column gas chromatography with nitrogen-sensitive detection. , 1982, Journal of chromatography.

[50]  J. Axelrod,et al.  The disposition and metabolism of tryptamine and the in vivo formation of 6-hydroxytryptamine in the rabbit. , 1971, The Journal of pharmacology and experimental therapeutics.

[51]  Guoxiang Shen.  CENTER FOR DRUG EVALUATION AND RESEARCH , 2020 .